본문 바로가기
KERD
논문KCI 등재

Is Complementary and Alternative Therapy Effective for Women in the Climacteric Period?

2

조회

0

다운로드

5

인용

0

참고문헌

키워드

초록

Vasomotor symptoms start about 2 years prior to menopause in women who are approaching menopause, and early menopause symptoms appear including emotional disturbance and anxiety, followed by physical changes such as vaginal dryness, urinary incontinence and skin wrinkles. As time progresses, osteoporosis, cardiovascular diseases, and dementia occur consecutively. Hormone therapy is primarily considered for the relief of menopause symptoms in postmenopausal women. However, as hormone replacement has emerged as a therapy that increases the potential risk of thrombosis, cerebral infarction and breast cancer, complementary and alternative medicine has drawn much attention. This study aimed to examine the types and effects of evidence-based complementary and alternative therapies that are currently used. (J Menopausal Med 2015;21:28-35)

Abstract

Vasomotor symptoms start about 2 years prior to menopause in women who are approaching menopause, and early menopause symptoms appear including emotional disturbance and anxiety, followed by physical changes such as vaginal dryness, urinary incontinence and skin wrinkles. As time progresses, osteoporosis, cardiovascular diseases, and dementia occur consecutively. Hormone therapy is primarily considered for the relief of menopause symptoms in postmenopausal women. However, as hormone replacement has emerged as a therapy that increases the potential risk of thrombosis, cerebral infarction and breast cancer, complementary and alternative medicine has drawn much attention. This study aimed to examine the types and effects of evidence-based complementary and alternative therapies that are currently used. (J Menopausal Med 2015;21:28-35)

참고문헌 (65)

  1. "Complementary, alternative, or integrative health: what’ s in a name? Bethesda" (2008)[URL]
  2. Geller SE., "Botanical and dietary supplements for menopausal symptoms : what works, what does not", J Womens Health(Larchmt), 14, pp.634~649 (2005)
  3. Pitkin J., "Alternative and complementary therapies for the menopause", Menopause Int, 18, pp.20~27 (2012)
  4. Zand RS., "Steroid hormone activity of flavonoids and related compounds", Breast Cancer Res Treat, 62, pp.35~49 (2000)
  5. Kuiper GG., "Cloning of a novel receptor expressed in rat prostate and ovary", Proc Natl Acad Sci U S A, 93, pp.5925~5930 (1996)
  6. Kuiper GG., "Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta", Endocrinology, 139, pp.4252~4263 (1998)
  7. Lindner HR, "Occurrence of anabolic agents in plants and their importance", Environ Qual Saf, (Suppl), pp.151~158 (1976)
  8. Farnsworth NR., "Potential value of plants as sources of new antifertility agents II", J Pharm Sci, 64, pp.717~754 (1975)
  9. Kelly GE., "The variable metabolic response to dietary isoflavones in humans", Proc Soc Exp Biol Med, 208, pp.40~43 (1995)
  10. Joannou GE., "A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids", J Steroid Biochem Mol Biol, 54, pp.167~184 (1995)
  11. Kelly GE., "Metabolites of dietary(soya)isoflavones in human urine", Clin Chim Acta, 223, pp.9~22 (1993)
  12. Setchell KD., "Dietary isoflavones: biological effects and relevance to human health", J Nutr, 129, pp.758S~767S (1999)
  13. Jacobs A., "Efficacy of isoflavones in relieving vasomotor menopausal symptoms-A systematic review", Mol Nutr Food Res, 53, pp.1084~1097 (2009)
  14. Tempfer CB., "Phytoestrogens in clinical practice : a review of the literature", Fertil Steril, 87, pp.1243~1249 (2007)
  15. Setchell KD., "Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability", Am J Clin Nutr, 76, pp.447~453 (2002)
  16. Messina M., "Skeletal benefits of soy isoflavones : a review of the clinical trial and epidemiologic data", Curr Opin Clin Nutr Metab Care, 7, pp.649~658 (2004)
  17. Ma DF., "Soy isoflavone intake increases bone mineral density in the spine of menopausal women : meta-analysis of randomized controlled trials", Clin Nutr, 27, pp.57~64 (2008)
  18. Food and Drug Administration., "Food labeling: health claims; soy protein and coronary heart disease", Food and Drug Administration, HHS. Final rule. Fed Regist, 64, pp.57700~57733 (1999)
  19. Rudkowska I., "Functional foods for cardiovascular disease in women", Menopause Int, 14, pp.63~69 (2008)
  20. Dodin S., "The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women : a randomized, double-blind, wheat germ placebocontrolled clinical trial", J Clin Endocrinol Metab, 90, pp.1390~1397 (2005)
  21. Lewis JE., "A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause", Menopause, 13, pp.631~642 (2006)
  22. Simbalista RL., "Consumption of a flaxseed-rich food is not more effective than a placebo in alleviating the climacteric symptoms of postmenopausal women", J Nutr, 140, pp.293~297 (2010)
  23. Lucas EA., "Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women", J Clin Endocrinol Metab, 87, pp.1527~1532 (2002)
  24. Pan A., "Meta-analysis of the effects of flaxseed interventions on blood lipids", Am J Clin Nutr, 90, pp.288~297 (2009)
  25. Borrelli F., "Black cohosh(Cimicifuga racemosa)for menopausal symptoms : a systematic review of its efficacy", Pharmacol Res, 58, pp.8~14 (2008)
  26. Nadaoka I., "Oral administration of Cimicifuga racemosa extract affects immobilization stress-induced changes in murine cerebral monoamine metabolism", Biomed Res, 33, pp.133~137 (2012)
  27. Borrelli F., "Alternative and complementary therapies for the menopause", Maturitas, 66, pp.333~343 (2010)
  28. Al-Akoum M., "Effects of Hypericum perforatum(St. John's wort)on hot flashes and quality of life in perimenopausal women : a randomized pilot trial", Menopause, 16, pp.307~314 (2009)
  29. Hirata JD., "Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial", Fertil Steril, 68, pp.981~986 (1997)
  30. Kupfersztain C., "The immediate effect of natural plant extract, Angelica sinensis and Matricaria chamomilla(Climex)for the treatment of hot flushes during menopause. A preliminary report", Clin Exp Obstet Gynecol, 30, pp.203~206 (2003)
  31. Chang A., "The effect of herbal extract(EstroG-100)on pre-, peri-and post-menopausal women : a randomized double-blind, placebo-controlled study", Phytother Res, 26, pp.510~516 (2012)
  32. Wiklund IK., "Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women : a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group", Int J Clin Pharmacol Res, 19, pp.89~99 (1999)
  33. 김명선, "Ginseng for managing menopause symptoms: a systematic review of randomized clinical trials", Journal of Ginseng Research, 37(1), pp.30~36 (2013), 고려인삼학회
  34. Hartley DE., "Effects on cognition and mood in postmenopausal women of 1-week treatment with Ginkgo biloba", Pharmacol Biochem Behav, 75, pp.711~720 (2003)
  35. Elsabagh S., "Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba", J Psychopharmacol, 19, pp.173~181 (2005)
  36. Heyerick A., "A first prospective, randomized, doubleblind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts", Maturitas, 54, pp.164~175 (2006)
  37. Erkkola R., "A randomized, double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts", Phytomedicine, 17, pp.389~396 (2010)
  38. MacEoin B., "Homeopathy for women" (1996), Hodder and Stroughton
  39. Bordet MF., "Treating hot flushes in menopausal women with homeopathic treatment--results of an observational study", Homeopathy, 97, pp.10~15 (2008)
  40. Cucherat M., "Evidence of clinical efficacy of homeopathy. A meta-analysis of clinical trials. HMRAG. Homeopathic Medicines Research Advisory Group", Eur J Clin Pharmacol, 56, pp.27~33 (2000)
  41. Ernst E., "A systematic review of systematic reviews of homeopathy", Br J Clin Pharmacol, 54, pp.577~582 (2002)
  42. Thompson EA., "Designing clinical trials of homeopathy for menopausal symptoms : a review of the literature", Menopause Int, 15, pp.31~34 (2009)
  43. Shanafelt TD., "Pathophysiology and treatment of hot flashes", Mayo Clin Proc, 77, pp.1207~1218 (2002)
  44. Berendsen HH., "The role of serotonin in hot flushes", Maturitas, 36, pp.155~164 (2000)
  45. Stearns V., "Paroxetine controlled release in the treatment of menopausal hot flashes : a randomized controlled trial", JAMA, 289, pp.2827~2834 (2003)
  46. Stearns V., "Paroxetine is an effective treatment for hot flashes : results from a prospective randomized clinical trial", J Clin Oncol, 23, pp.6919~6930 (2005)
  47. Simon JA., "Low-dose paroxetine 7. 5 mg for menopausal vasomotor symptoms : two randomized controlled trials", Menopause, 20, pp.1027~1035 (2013)
  48. Orleans RJ., "FDA approval of paroxetine for menopausal hot flushes", N Engl J Med, 370, pp.1777~1779 (2014)
  49. Loprinzi CL., "Phase III evaluation of fluoxetine for treatment of hot flashes", J Clin Oncol, 20, pp.1578~1583 (2002)
  50. Barton DL., "Pilot evaluation of citalopram for the relief of hot flashes", J Support Oncol, 1, pp.47~51 (2003)
  51. Barton DL., "Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes : NCCTG trial N05C9", J Clin Oncol, 28, pp.3278~3283 (2010)
  52. Loprinzi CL., "Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors", J Clin Oncol, 16, pp.2377~2381 (1998)
  53. Loprinzi CL., "Venlafaxine in management of hot flashes in survivors of breast cancer : a randomised controlled trial", Lancet, 356, pp.2059~2063 (2000)
  54. Loprinzi CL., "Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes : North central cancer treatment group trial N99C7", J Clin Oncol, 24, pp.1409~1414 (2006)
  55. Jin Y., "CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment", J Natl Cancer Inst, 97, pp.30~39 (2005)
  56. Otton SV., "Venlafaxine oxidation in vitro is catalysed by CYP2D6", Br J Clin Pharmacol, 41, pp.149~156 (1996)
  57. Guttuso TJ. Jr., "Gabapentin's effects on hot flashes and hypothermia", Neurology, 54, pp.2161~2163 (2000)
  58. Guttuso T. Jr., "Gabapentin's effects on hot flashes in postmenopausal women : a randomized controlled trial", Obstet Gynecol, 101, pp.337~345 (2003)
  59. Pandya KJ., "Gabapentin for hot flashes in 420 women with breast cancer : a randomised double-blind placebocontrolled trial", Lancet, 366, pp.818~824 (2005)
  60. Cho SH., "Acupuncture for vasomotor menopausal symptoms : a systematic review", Menopause, 16, pp.1065~1073 (2009)
  61. Borud EK., "The acupuncture on hot flushes among menopausal women(ACUFLASH)study, a randomized controlled trial", Menopause, 16, pp.484~493 (2009)
  62. Kim KH., "Effects of acupuncture on hot flashes in perimenopausal and postmenopausal women--a multicenter randomized clinical trial", Menopause, 17, pp.269~280 (2010)
  63. Elraiyah T., "Clinical review : The benefits and harms of systemic dehydroepiandrosterone(DHEA)in postmenopausal women with normal adrenal function : a systematic review and meta-analysis", J Clin Endocrinol Metab, 99, pp.3536~3542 (2014)
  64. 류언나, "간호사의 호르몬 대체요법에 대한 지식 및 태도", 대한폐경학회지, 18(1), pp.43~51 (2012), 대한폐경학회[DOI]
  65. Lee SW., "Bioidentical hormone therapy in postmenopausal women", J Korean Soc Menopause, 16, pp.6~15 (2010)

관련 논문AI추천

이 간행물의 다른 논문 (8건)